2026 IPO boom is just SpaceX plus 43 underperformers

The Gist

• SpaceX's $1.77T IPO accounts for 99% of 2026's VC-backed IPO value
• Other 43 IPOs combined worth just $17B, with many down 30%+ from debut
• SaaS companies largely absent from this year's public markets

• The 2026 IPO boom is largely driven by SpaceX, with the other 43 VC-backed IPOs combined worth only $17 billion.
• Public investors are pricing cash flows rather than narratives, leading to a significant gap between private and public valuations.
• Enterprise software IPOs have gone quiet, with no venture-backed B2B unicorns filing to go public in 2026.
• Consumption-priced infrastructure benefiting from AI is outperforming seat-priced application software that AI might replace.
• Biotech IPOs have outperformed the AI IPO class, indicating public investors favor binary clinical outcomes over compute narratives.
• The Renaissance IPO Index shows recent IPOs as a class are beating the market, suggesting the aftermath isn't uniformly bad.

• Evaluate the gap between private and public valuations before considering an IPO.
• Focus on consumption-priced infrastructure that benefits from AI rather than seat-priced application software.
• Consider alternative sectors like biotech for IPO opportunities, where public investors are showing more interest.
• Monitor the Renaissance IPO Index for trends in recent IPO performance.

• $1,786.8 billion (Total US VC-backed IPO value through July 28, 2026.)
• $1.77 trillion (SpaceX's valuation at IPO.)
• $75 billion (Amount raised by SpaceX in its IPO.)
• $17 billion (Combined worth of the other 43 VC-backed IPOs in 2026.)
• 55% (Bloomberg biotech IPO index performance through July 21, 2026.)
• 12.7% (Renaissance IPO Index performance through July 2026.)